Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease

• Status: Completed
• Trial end date: 2011-10-01
• Target enrollment: 0
• Participant gender: All

Summary

Investigate the Safety and Efficacy of Two Concentrations of DE-110 Compared to Placebo for the Treatment of Dry Eye Disease

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Santen Inc.

Criteria

Inclusion Criteria:

• Confirmed diagnosis of dry eye

• Not wear contact lenses during study

• 18 years or older

• Understand and provide written consent

• Negative pregnancy test and use acceptable method of contraception

Exclusion Criteria:

• Use of any topical ocular medication

• Any type of ocular surgery

• Diagnosis of on-going ocular infection and/or allergic conjunctivitis

• Uncontrolled systemic conditions/lid abnormalities

• Corneal transplants

• Females who are pregnant, nursing or planning a pregnancy

• Participation in another drug trial concurrently or within 30 days prior to study